CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.
Cancer medicine（2023）
摘要
CEACAM6 may serve as a potential biomarker in diagnosing LUAD-LM.
更多查看译文
关键词
CEACAM6,biomarker,leptomeningeal metastasis,lung adenocarcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要